We are authorized to grant shares for equity incentive awards. The remaining shares authorized for future issuance were 12.4 million at August 2, 2026. In December 2025, we granted stock options to employees for the purchase of 161 thousand shares of common stock at an exercise price of $468.90 per share and a binomial lattice model fair value of $125.96 per share at the grant date. At August 2, 2026, options for 936 thousand shares were outstanding with a weighted-average exercise price of $362.42 per share.

During the nine months ended August 2, 2026, the restricted stock units (RSUs) granted in thousands of shares and the weighted-average grant date fair values, using the closing price of our common stock on the grant date in dollars, follow:


		Grant-Date
		Fair Value
	Shares	(per share)
Service-based	315	$	475.79
Performance/service-based	154		538.25
Market/service-based (fair value determined using a Monte Carlo model)	39		555.14

In March 2026, we granted performance/service-based awards to certain of our senior officers, which vest subject to the satisfaction of pre-established annual Shareholder Value Added targets during a five-fiscal year period beginning on November 3, 2025, and ending on October 27, 2030. Each fiscal year, a payout percentage ranging from zero to 175% will be calculated and the five annual payout percentages will be averaged at the end of the performance period and used to calculate the number of common stock shares to be received. The awards include dividend equivalent payments.